Exact Sciences
EXAS
#1165
Rank
NZ$33.94 B
Marketcap
NZ$177.80
Share price
0.00%
Change (1 day)
124.40%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$9.02. In 2024 the company made an earnings per share (EPS) of NZ-$9.44.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.42-0.19%
2024NZ-$9.44
2022NZ-$6.002.31%
2021NZ-$5.86-38.54%
2020NZ-$9.54692.96%
2019NZ-$1.20-50.69%
2018NZ-$2.4444%
2017NZ-$1.69-39.39%
2016NZ-$2.80-2.94%
2015NZ-$2.8837.1%
2014NZ-$2.1079.71%
2013NZ-$1.17-21.59%
2012NZ-$1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.50-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$1.42-115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.58-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.34-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$86.27 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA